Comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 vs 14q24 1q24 3 Microdeletion Syndrome C4750911
Clinical comparison between 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia and 14q24 1q24 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
An inherited disorder affecting adrenal hormone production, causing cortisol deficiency and other hormonal imbalances. Features may include ambiguous genitalia, salt-wasting crises, and growth issues. Treated with lifelong hormone replacement therapy.
14q24 1q24 3 Microdeletion Syndrome C4750911
A rare genetic deletion involving part of chromosome 14. It can affect development and lead to various medical issues. Management focuses on supportive care and addressing specific needs.
6 comparison axes
Onset
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
0-null
14q24 1q24 3 Microdeletion Syndrome C4750911
0-null
Onset patterns differ
Severity
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
severe
14q24 1q24 3 Microdeletion Syndrome C4750911
moderate
Different severity levels
Chronic
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
Chronic
14q24 1q24 3 Microdeletion Syndrome C4750911
Chronic
Differing course
Communicable
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
No
14q24 1q24 3 Microdeletion Syndrome C4750911
No
Different transmission
Body System
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
14q24 1q24 3 Microdeletion Syndrome C4750911
congenital
Same/different system
Category
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
endocrine
14q24 1q24 3 Microdeletion Syndrome C4750911
genetic
Different category
Bottom line
21-hydroxylase-deficient-congenital-adrenal-hyperplasia-C2936858 and 14q24-1q24-3-microdeletion-syndrome-C4750911 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Discriminating power |
|---|---|---|---|
| Hormone pattern | Cortisol deficiency with possible androgen excess and salt loss | Not described as a primary adrenal hormone disorder | High |
| Early physical findings | Ambiguous genitalia or growth issues may occur | Developmental or congenital issues may occur; specifics are not established | Moderate |
| Acute illness | Salt-wasting adrenal crisis is a recognized concern | No characteristic adrenal crisis is established here | High |
When to favor each condition
Choose 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 when
Suspected newborn salt-wasting or ambiguous genitalia
This pattern fits the described endocrine disorder better
Moderate
Steroid testing suggests 21-hydroxylase deficiency
Supports CAH pending confirmatory clinical and genetic review
Moderate
Recessive adrenal disorder is suspected in the family
Fits CAH better, although inheritance details here are limited
Low
Choose 14q24 1q24 3 Microdeletion Syndrome C4750911 when
Microarray identifies a 14q24.1-q24.3 deletion
A detected deletion directly supports this syndrome
High
Multisystem developmental findings without adrenal imbalance
Better matches the described chromosomal condition
Moderate
Adrenal evaluation does not support CAH
Makes 21-hydroxylase deficiency less likely but does not prove the deletion
Moderate
How key tests differ
| Test | 21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Interpretation |
|---|---|---|---|
| Adrenal steroid profile | May be abnormal, often with elevated 17-hydroxyprogesterone | No diagnostic steroid pattern is established | An abnormal result suggests CAH but is not a complete diagnosis |
| Serum electrolytes | Salt-wasting may cause low sodium and high potassium | No characteristic electrolyte pattern is established | Interpret clinically; exact cutoffs are not supplied |
| Chromosomal microarray | Not expected to show this deletion | May identify the 14q24.1-q24.3 deletion | A positive result supports the deletion; specialist review is needed |
Prognosis comparison
21 Hydroxylase Deficient Congenital Adrenal Hyperplasia C2936858
- Outcome
- Chronic condition whose outcome varies with crisis prevention and hormone management; mortality is not established here.
- Factors
- Salt-wasting risk, early recognition, and treatment adherence
14q24 1q24 3 Microdeletion Syndrome C4750911
- Outcome
- Chronic rare condition; prognosis is not established and may depend on associated problems.
- Factors
- Deletion extent and developmental or medical needs
Time frame: Both are described as chronic or lifelong; exact timelines are not established.
Specialist follow-up and individualized support influence care needs.
Complications comparison
| Complication | Presentation |
|---|---|
| Adrenal crisis | Possible with cortisol and aldosterone deficiency Not established from the supplied description Urgent assessment is needed for vomiting, lethargy, or dehydration |
| Growth concerns | Possible from hormone imbalance or treatment effects Possible but no specific growth pattern is established Growth should be monitored individually |
| Developmental needs | Not the main described feature Various developmental or medical issues may occur Supportive care should match identified needs |
Patient education highlights
- HighEmergency symptoms
Seek urgent care for poor feeding, vomiting, lethargy, or dehydration, particularly when CAH is suspected.
- HighResult versus diagnosis
An abnormal laboratory result is not automatically a confirmed diagnosis and needs clinician interpretation.
- MediumLong-term care
CAH commonly needs lifelong hormone replacement; deletion care is supportive and individualized.